Clinical Trials Browser

Phase 1/2 × Urinary Bladder Neoplasms × Ipilimumab × Clear all

NCT04863885 2025-12-17

Combination of Ipi/Nivo Plus Sacituzumab Govitecan in Metastatic Cisplatin Ineligible Urothelial Carcinoma Patients

Phase 1/2 Active not recruiting

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT03844256 2022-08-12

CRIMI

Phase 1/2 Recruiting

Urinary Bladder Neoplasms